S100a8 and S100a9 were reported to be highly expressed in FACS purified CD11B+CD11C- microglia, associated with the inflammatory response in a mouse model of AD, as opposed to CD11B+CD11C+ microglia, postulated to have a protective immune-modulatory phenotype [78]. This evidence concerns the gene S100A9 and Alzheimer disease.